Kural, R.F.; Tunakan Dalgıç, C.; Özeke, Y.; Okan, K.; Afşin, S.; Gümüşburun, R.; Kırdök, K.; Galata, Z.; Toksoy Şentürk, M.İ.; Ateş, Ü.;
et al. Immediate-Type PPI Hypersensitivity as a Severe Adverse Drug Reaction: Diagnostic Challenges, Cross-Reactivity, and Real-Life Outcomes. J. Clin. Med. 2026, 15, 1808.
https://doi.org/10.3390/jcm15051808
AMA Style
Kural RF, Tunakan Dalgıç C, Özeke Y, Okan K, Afşin S, Gümüşburun R, Kırdök K, Galata Z, Toksoy Şentürk Mİ, Ateş Ü,
et al. Immediate-Type PPI Hypersensitivity as a Severe Adverse Drug Reaction: Diagnostic Challenges, Cross-Reactivity, and Real-Life Outcomes. Journal of Clinical Medicine. 2026; 15(5):1808.
https://doi.org/10.3390/jcm15051808
Chicago/Turabian Style
Kural, Ragıp Fatih, Ceyda Tunakan Dalgıç, Yusuf Özeke, Kasım Okan, Salih Afşin, Reyhan Gümüşburun, Kutay Kırdök, Züleyha Galata, Meryem İrem Toksoy Şentürk, Ümitcan Ateş,
and et al. 2026. "Immediate-Type PPI Hypersensitivity as a Severe Adverse Drug Reaction: Diagnostic Challenges, Cross-Reactivity, and Real-Life Outcomes" Journal of Clinical Medicine 15, no. 5: 1808.
https://doi.org/10.3390/jcm15051808
APA Style
Kural, R. F., Tunakan Dalgıç, C., Özeke, Y., Okan, K., Afşin, S., Gümüşburun, R., Kırdök, K., Galata, Z., Toksoy Şentürk, M. İ., Ateş, Ü., Aslan, E., Gökmen, E. N. M., & Sin, A. Z.
(2026). Immediate-Type PPI Hypersensitivity as a Severe Adverse Drug Reaction: Diagnostic Challenges, Cross-Reactivity, and Real-Life Outcomes. Journal of Clinical Medicine, 15(5), 1808.
https://doi.org/10.3390/jcm15051808
